The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Abbott Laboratories

NYSE: ABT
Last

(U.S.) $51.41

Today's change-0.67 -1.29%
Updated September 19 4:03 PM EDT. Delayed by at least 15 minutes.
 

Abbott Laboratories

NYSE: ABT
Last

(U.S.) $51.41

Today's change-0.67 -1.29%
Updated September 19 4:03 PM EDT. Delayed by at least 15 minutes.

Abbott Laboratories down (U.S.)$0.67

Abbott Laboratories closed lower Tuesday, dropping (U.S.)$0.67 or 1.29% to (U.S.)$51.41. Shares have lost 1.61% over the last five days, but sit 2.26% below their 52-week high. This security has outperformed the S&P 500 by 6.16% during the last year.

Key company metrics

  • Open(U.S.) $52.15
  • Previous close(U.S.) $52.08
  • High(U.S.) $52.24
  • Low(U.S.) $51.37
  • Bid / Ask-- / --
  • YTD % change+33.85%
  • Volume3,790,880
  • Average volume (10-day)4,892,107
  • Average volume (1-month)4,596,927
  • Average volume (3-month)5,748,188
  • 52-week range(U.S.) $37.38 to (U.S.) $52.60
  • Beta1.57
  • Trailing P/E78.94×
  • P/E 1 year forward20.91×
  • Forward PEG1.86×
  • Indicated annual dividend(U.S.) $1.06
  • Dividend yield2.06%
  • Trailing EPS(U.S.) $0.65
Updated September 19 4:03 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.37%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue6,6376,3355,3335,302
Total other revenue--------
Total revenue6,6376,3355,3335,302
Gross profit3,4643,2913,0233,017
Total cost of revenue3,1733,0442,3102,285
Total operating expense6,2106,5374,3854,405
Selling / general / administrative2,1322,2991,6061,618
Research & development513541338352
Depreciation / amortization392522121140
Interest expense (income), net operating--------
Unusual expense (income)--1311010
Other operating expenses, total--------
Operating income427-202948897
Interest income (expense), net non-operating-214-226-153-117
Gain (loss) on sale of assets--------
Other--------
Income before tax295736875-179
Income after tax270386765-357
Income tax, total25350110178
Net income283419798-329
Total adjustments to net income--------
Net income before extra. items270386765-357
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items270386765-357
Inc. avail. to common incl. extra. items283419798-329
Diluted net income283419798-329
Dilution adjustment------0
Diluted weighted average shares1,7411,7351,4841,476
Diluted EPS excluding extraordinary itemsvalue per share0.160.220.52-0.24
Dividends per sharevalue per share0.270.270.260.26
Diluted normalized EPSvalue per share0.160.260.52-0.24